US 11932852
Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof
granted A61PA61P21/00A61P27/02
Quick answer
US patent 11932852 (Reagents for treatment of oculopharyngeal muscular dystrophy (OPMD) and use thereof) held by Benitec IP Holdings Inc. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Benitec IP Holdings Inc.
- Grant date
- Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61P, A61P21/00, A61P27/02